Previous reports indicating a decreased EAAT2 expression in animal models of PD, including the 6-hydroxydopamine lesioned PD model63 and the acute 1-methyle-4-phenyl-1,2,3,6-tetrahydropyridine treated model64, also partially support our data. The gene discussed is SLC1A2; the disease is Parkinson disease.